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The efficacy of the procedures in use at the two rendering
plants in the Netherlands was assessed on a laboratory-scale
using procedures that simulated the pressure cooking part of
the rendering process. A pool of bovine spongiform
encephalopathy (BsE)-infected brainstem from the United
Kingdom and a pool of scrapie-infected brainstem from Dutch
sheep were used to spike the rendering materials. The mix-
tures were subjected to various time-temperature combina-
tions of hyperbaric heat treatment related to the conditions
used in Dutch rendering plants in the early 1990s, and to the
combination of 20 minutes at 133°C required by the EU
Directive on rendering of 1996. The efficacy of the procedures
in inactivating BSE or scrapie infectivity was measured by
titrating the materials before and after heat treatment in
inbred mice, by combined intracerebral and intraperitoneal
inoculations at limiting dilutions. Two independent series of
experiments were carried out. The design of the study allowed
for minimum inactivations of up to 2-2 log (2-0 in the second
series) to be measured in the diluted infective material and 3-1
log in the undiluted material. After 20 minutes at 133°C there
was a reduction of BSE infectivity of about 2-2 log in the first
series (with some residual infectivity detected), and in the sec-
ond series more than 2-0 log (with no residual infectivity
detected). With undiluted brain material there was an inacti-
vation of about 3-0 log (with some residual infectivity detect-
ed). With the same procedure, scrapie infectivity was reduced
by more than 1-7 log in the first series and by more than 2-2
log in the second series. With undiluted brain material there
was an inactivation of more than 3-1 log. In each case no resid-
ual scrapie infectivity was detected. The BSE agent consistently
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appeared to be more resistant to heat inactivation procedures
than the scrapie agent, particularly at lower temperatures and
shorter times.
BOVINE spongiform encephalopathy (BSE) has become a major
veterinary problem in cattle over the last decade. Not only animal
health is at stake, there are also implications for public health. The
recognition of the BSE agent as a possible cause of a new variant
of Creutzfeldt-Jakob disease (vCJD) in human beings (Will and
others 1996) had placed BSE in a spotlight which was accentuated
by confirmatory data indicating that there is a link between this
form of CJD and BSE (Bruce and others 1997, Hill and others
1997). The resulting public concern about the zoonotic potential
of the disease reaches far beyond the borders of the UK and has
determined the need for the assurance of a 'safe food chain'.
Early in the BSE epizootic, it was concluded on the basis of epi-
demiological data that cows had contracted the disease through eat-
ing meat and bone meal infected with a transmissible spongiform
encephalopathy agent, possibly originating from scrapie-infected
sheep (Wilesmith and others 1988, 1991). In the UK in the late
1970s and early 1980s rendering conditions had been changed to
conditions which apparently inactivated the BSE agent insufficient-
ly. It is now generally accepted that the recycling of BSE-infected
material in cattle was the key factor in driving the epizootic. The
risks associated with the import of products possibly contaminated
with BSE or of BSE-infected animals, and the possibility that BSE
might emerge as a result of the recycling of indigenous scrapie
infectivity, prompted the evaluation of rendering procedures in the
Netherlands.
The difficulty of inactivating the agents causing transmissible
spongiform encephalopathies (TSEs) or prion diseases, had been
established before BSE emerged by thermal inactivation studies
with the agents causing scrapie or CJD (Kimberlin and others
1983, Taylor 1991). For the inactivation of most strains of scrapie
moist heating at hyperbaric pressures of 20 psi (=2-4 bar) at 126°C
seemed to be effective. For the most thermoresistant scrapie
strain, 22A, four minutes exposure at 30 psi (=3-1 bar) at 136°C
proved to be effective, when porous load autoclaving procedures
were used. However, the results of later studies proved to be less
reassuring (Taylor and others 1994).
The resistance of TSE agents to dry heat was even more notori-
ous, especially after reports that scrapie agent even resisted ashing,
at least in part (Brown and others 1990). So far, no experiment had
mimicked actual rendering conditions because almost all experi-
ments used brain macerates heated in autoclaves. The first render-
ing experiments with the BSE agent were reported by Taylor and
others (1995), and they were followed by similar rendering studies
with scrapie-infected materials (Taylor and others 1997). In these
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experiments, a range of rendering processes in use in the
European Union, including hyperbaric procedures, were evaluated
in pilot-scale facsimiles.
The present studies have been confined to variations within the
hyperbaric process, and were designed to assess the efficacy of
the Dutch rendering processes in inactivating the causative agents
of BSE and scrapie. Because heat treatment at high temperature
under hyperbaric conditions ('pressure cooking') is considered the
critical part of the inactivation process, only this part of the ren-
dering process was evaluated. The possible effects of other com-
ponents of the rendering process were not considered.
In the early 1990s, this pressure cooking was performed at one
of the two Dutch rendering plants (plant A) as a batch process,
and at the other plant (plant B) as a continuous process. The
Dutch Rendering Directive, in force at the time of inception of the
study (1990/91), specified minimum holding times of 10 and 15
minutes, for the continuous and batch processing plants, respec-
tively, at temperatures above 130°C under hyperbaric conditions.
These minimal requirements were in addition to specified longer
holding times at lower temperatures. In validation studies, using
chromium and cobalt as markers for the solid and liquid phase,
respectively, the actual conditions in the continuous process were
evaluated (results not reported here). Since 1996 both plants have
used a batch processing system with a minimum holding time of
20 minutes at 133°C, thus complying with current EU directives.
This paper describes laboratory studies with rendering materials
spiked with BSE or scrapie agent in different well defined, hyperbar-
ic inactivation cycles, which were based on the procedures in use at
the plants when the study began and also included the present EU-
recommended procedure. The aims of the study were first to assess
the efficacy of an essential part of the Dutch rendering process in
eliminating BSE and scrapie agents from the animal food chain, and
secondly, to determine the kinetics of the inactivation processes.
Materials and methods
Collection and preparation of the material used for spiking
One of the limitations of previous rendering experiments
(Taylor and others 1995) was the low initial titre in the spiking
material. Because brainstem material, especially in the caseof BSE,
would contain higher titres of infectivity than a mixture of whole
brain (Hadlow and others 1979, Scott and others 1990, R. Bradley,
personal communication), only brainstem material was used. The
following materials were collected and used for spiking:
a) Brainstems from six histologically confirmed usE-affected
cattle, originating from five different farms (made available
by kind permission of Dr Keith Meldrum, cvo, UK).
b) Brainstems from 60 histologically confirmed scrapie-affected
sheep, collected from 38 different farms throughout the
Netherlands. No more than five brainstems per farm were
included. Materials from at least eight different breeds of
sheep (including foreign breeds) or their crosses were
involved.
Approximately half of each paramedically cut brainstem was
available for these experiments. Both theBSE and scrapie brain
materials were homogenised in a Sorvall Omni-mixer. TheBSE
material was homogenised without adding other material, the
scrapie material was diluted to a 66-6 per cent suspension in
saline, to facilitate mixing. The scrapie material was first mixed in
batches of five samples each, after which a final pool was pre-
pared from these initial batches. The brain materials were divided
into appropriate aliquots and stored at -20°C until used.
Material tested
The infectious spiking materials were mixed with raw material
for dilution. The raw material, mainly abattoir waste and predomi-
nantly of porcine origin, was obtained from one of the rendering
plants as crushed and heat-treated (<95°C) material containing 70
per cent water, 14 per cent protein,10 per cent fat and 6 per cent
ash; it was considered to have a typical composition for this stage
in the process. This crushed material was further homogenised in a
Sorvall Omni-mixer and finally mixed with the spike material to
obtain a 10 per cent w/w mixture of spike material in partially ren-
dered material. Thirty millilitre glass vials, 'universal bottles', with
a screw-cap were then two-thirds filled with the spiked rendering
material for exposure to various hyperbaric heat treatment cycles.
Equipment
The heat treatment cycles were carried out in an autoclave with
internal monitoring of conditions. For this purpose a 25 litre steam
steriliser was adapted to allow the temperature to be set adequately
and the exposure time to be interrupted immediately after the
required test period had elapsed. To control and monitor the expo-
sure conditions, a pressure-temperature measuring system was
used, because after all air has been removed, pressure is the most
accurate way to control the temperature. This system complies
with the requirements of EN 285 (EN 285 1997) in that it measures
one pressure with an accuracy of 1 kPa and at least five tempera-
tures with an accuracy better than 0-5°C. Before each test series the
entire measuring system was calibrated against in-house standards.
Dummy vials were used to monitor the temperature; they were
identical to the sample vials but contained clean, unspiked materi-
al, that is, rendering material to which 10 per cent negative brain
material had been added. One of the temperature sensors was
placed inside a dummy sample vial in the centre, at one third of
the material level (from the bottom). This position had been
demonstrated to be the most critical position within the material to
be treated (J. van Asten, unpublished observations). During the
heat treatment cycles, the dummy vial was placed adjacent to the
sample vials. Owing to the relatively small volume of the vials
and the saturated steam heat-up cycle, the temperature differences
within each vial and between the vials were considered negligible.
Both the sample vials and the dummy vials containing the tem-
perature sensors were hermetically sealed, and no additional
steam was added or injected into the vials. With 70 per cent water,
the moisture in the sample materials is considered sufficient to
create an internal liquid- or steam-saturated micro-environment
within the vials which mimics the large-scale rendering processes
in the Netherlands, where heating takes place in closed, steam-
jacketed vessels, without steam being injected into the vessels.
The temperature in the dummy vial was monitored throughout
the cycle. The exposure time started when the recorded tempera-
ture reached the planned test temperature, and this temperature
was maintained for the required period after which the steriliser
was vented and the contents allowed to cool down. The sample
vials were stored at -20°C pending bioassay.
Experimental procedures
All the experiments, including the preparation of the samples,
were carried out in duplicate, in two independent series of experi-
ments (series 1 and 2) and with bothBSE and scrapie brainstems as
spike material. The following temperature-time cycles were tested
in separate test runs:
A) three minutes at 105°C (survival of infectivity expected);
B) three minutes at 121°C (survival of infectivity expected);
C) fifteen minutes at 125°C (theoretical worst case scenario in
plant Ain 1993*);
D) three minutes at 134°C (theoretical worst case scenario in
plant B in 1993*);
E) twenty minutes at 133°C (Ec directive 90/667, for high risk
material);
P) twenty minutes at 133°C (Ec directive 90/667), in series 2
withundilutedbrainstem material only.
*These conditions were considered the theoretical worst case sce-
narios for any material at the start of the experiments (around
1993) for both plants in the Netherlands. Both plants now operate
as batch processing plants and comply with current EU directives
(Commission Decision 1996).
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In order to maximise the initial titre, one set of tests was run
with undiluted spike material at the temperature/time combination
having what was presumed to be the highest efficiency (20 min-
utes at 133°C) (process P in series 2).
Bioassay in mice
For the bioassay, parent stock of three mouse strains RIII/FaDk-ro,
C57BL and VM mice, was obtained from the Neuropathogenesis
Unit (NPU), Edinburgh, of the Institute of Animal Health, by kind
permission of Dr C. Bostock. The material used for spiking was
titrated in 10-fold dilutions (six or seven steps) in groups of six to
eight mice for each dilution: BSE brainstem material in RIII/FaDk-ro
mice, and scrapie brainstem material in C57BL and VM mice. The
heat-treated spiked material was also assayed undiluted and in 10-
and 100-fold dilutions, in groups of 15 or 16 mice of the same
strains. In addition, in the lowest time-temperature combination
(three minutes at 105°C) one extra dilution step was included. Not
all the tests with scrapie material were done in C57BL and in VM
mice because of breeding difficulties with the VM strain and
because of hypersensitivity to the antibiotic solution with the
C57BL strain. It was therefore necessary to resort temporarily to
RIII mice for the assay of scrapie material. Aliquots of the pooled
brainstem material used for spiking were diluted in antibiotic
solution containing 5000 iu penicillin and 5000 ,ug strepto-
mycin/ml. Aliquots of the heat-treated material were also diluted,
initially in the same solution, but after problems with the C57BL
mice it was replaced by sterile saline. No bacteriological screen-
ing was done and no problems related to possible bacteriological
contamination were encountered.
The mice were inoculated with 0.02 ml intracerebrally and with
0-5 ml intraperitoneally, essentially as described by Taylor and
others (1995). Each inoculum was prepared with an Ultra-Turrax
T25 homogeniser, and the homogeniser probes were decontami-
nated between usages by two cycles of porous-load autoclaving
for 30 minutes at 136°C, and washed with detergent in between.
The homogenates were centrifuged for five minutes at 500 g and
the supematants used for the bioassay.
The mice were observed and clinically monitored daily for a
period of up to 900 days. The brains of all mice surviving the first
ten days were examined histologically; they were immersion-
fixed in 10 per cent formol-saline and histological sections were
prepared from five different coronal sections; they were stained
with haematoxylin and eosin and examined microscopically for
the presence of spongiform lesions. The brains were also exam-
ined by immunohistochemistry, consisting of PrpSC staining with a
peptide-based antibody, R505, directed against murine PrpSC.
Positive results were based on both these techniques, and the pres-
ence of PrpSc was considered decisive.
Calculation of infectivity titre and reduction of titre
The results of the animal experiments can be expressed as the
infectivity of the samples per ml (or gram) of inoculum, in this
case the number of ID5O doses. This was calculated by the method
TABLE 1: Titres of infectivity in the pooled brainstem material (spike)
Titre (log ID50/g)
Brainstem Strain of Karber GLM
Experiment material mice method* (se)t
Series 1 Scrapie VM 3-1 2.8 (0-3)
Scrapie C57BL 3-5 35 (0-3)
BSE Rill 3-8 3.7 (0-4)
Series 2 Scrapie VM 2-4 2.4 (0-2)
Scrapie C57BL 3-4 3.4 (0-4)
BSE Rill 3-6 3.4 (0-2)
Calculated by the method of Karber (1931)
t Calculated using a generalised linear model (GLM) (se = standard error)
For both methods, corrected for the initial dilution step (66.6%) in the case of
scrapie
of Karber (1931) and by an altemative method which uses a gen-
eralised linear model (GLM). For the latter it was assumed that an
inoculum contains a number of equal BSE or scrapie particles
which all have an equal probability of inducing infection. The fol-
lowing dose-response model was therefore used:
response = 1 - e-dose x titre
Having thus estimated the average infective dose it was con-
verted, to allow comparison with the Karber method, to an ID50
titre.
For the titre calculations the number of positive mice was divid-
ed by the number of mice which survived until the first mouse in
the dilution group was confirmed positive. If there were no posi-
tive mice in any group, the data from the next lower dilution were
used. If the mortality in the undiluted group did not reach 100 per
cent, but the mortality in the next lower dilution did reach 100 per
cent, the result from the undiluted group was considered an arte-
fact (probably the best result of difficulties with inoculating undi-
luted material), and a 100 per cent score was assumed for the
undiluted group.
To calculate the reduction in titre caused by a particular pro-
cess, the titre was calculated back to the initial 100 per cent con-
centration of the spike. Values calculated by the Karber method
and those calculated by the GLM used their own reference values.
The extended incubation periods associated with heat-treated
material and the subsequent level of intercurrent mortality resulted
in small test groups, and limited the practical applicability of the
Karber method. The GLM method does not suffer from this draw-
back. However, in the conclusions and discussion, the results cal-
culated by the Karber method have been used so that they can be
related to other research data.
The reduction of the titre of infectivity caused by an inactiva-
tion process is an indication of the efficacy of that process, which
is determined by the temperature and the holding time. The inacti-
vation mechanism in the rendering process is, just like that in
steam sterilisation processes, the effect of moist heat on microor-
ganisms and/or transmissible agents. For steam sterilisation in
general the inactivation kinetics of microorganisms can be
described as a first order reaction. For this an equation is applica-
ble in which the decimation time D (the time needed for 1 log
reduction at a certain temperature) and the resistance coefficient z
(the effect of a temperature change on the decimation time) are
unknown variables. If the same equation were valid for the inacti-
vation kinetics of prions (which is unlikely given the information
from other inactivation studies with TSE agents [Taylor and Femie
1996]), it should be possible to determine these unknown vari-
ables from the results of a series of experiments in which several
'sub-lethal' inactivation processes have been applied.
Results
All the experiments were carried out in duplicate (series 1 and
2). The titres of infectivity in the pooled brainstem materials used
for spiking are shown in Table 1.
0 5 10 15 20 25 30 35 40 45 50 55
Time (min)
FIG 1: Temperature-time profiles of processes A, B, C, D and E
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TABLE 2: Reduction of titres of infectivity in the experiments of series 1
Titre after heat treatment Reduction factor*
Process Strain of (log ID50/g) (log 10)
Spiking agent Code (time/temp) mice Karber GLM (se) Karber GLM
Scrapie A 3 min/105°C Rill 3.9 3-9 (0-2) - -
B 3 min/121°C Rill 2.9 2.2 (0-2) 1.0 1.7
C 15 min/125°C RIII 2.0 1.2 (0.4) 1.9 2.7
C57BL <1.8 <1.1 >1.7* >2.4*
D 3min/134°C RiI <1.8 <1.1 >2.1 >2.8
C57BL <1.8 <1.1 >1 7* >2-4*
E 20 min/133°C VM <1.8 <1.1 >1.3* >1-7*
C57BL <1-8 <1.1 >1 7* >2-4*
BSE A 3 min/1050C RuIt 4-0 4.0 (0-2) - -
B 3 min/121°C RuII 3-8 3.8 (0-2) 0.2 0.2
C 15 min/1250C RIII 2.4 2.7 (0-3) 1 6 1.3
D 3 min/134°C RiII NC 1.9 (0-5) NC 2.1
E 20 min/1330C RIII =1-8 1.7 (0-2) =2-2 2.3
All titres were calculated by the method of Karber and using a generalised linear model (GLM) (se = standard error) and calculated back to 100 per cent brain
material
All titres indicated with 'smaller than' (<) had no detectable residual infectivity even in the highest concentration used in the bioassay (in this series applicable
to scrapie processes C, D and E only)
* The titre in process A (lowest heat exposure) was used as the reference titre. Only when a different mouse-line was used was the original spike titre used as
reference titre (indicated with *)
NC Not calculated owing to limited number of mice
The temperature profiles of the five different time-temperature
exposures A, B, C, D and E, as measured at the internal monitor-
ing points in the dummy vials, are given in Fig 1. There was a
penetration interval of about five minutes after which the heating
up period started, in general requiring between 10 and 15 minutes
until the planned temperatures were reached (Fig 1). Only one
profile for each cycle is shown, but the temperature profiles of the
two series of experiments were virtually congruent.
The impact of the various heat exposure cycles on the titres of
infectivity, as assayed in mice, are expressed in log ID5O/g of
undiluted spike material and shown in Tables 2 and 3 and Fig 2.
There was no reduction in titre as a result of process A, that is
three minutes at 105°C, whereas process B (three minutes at
121°C) caused about 1.0 log reduction in titre for scrapie, but not
for BSE infectivity. Process C, 15 minutes at 125°C, gave a reduc-
tion in titre of almost 2.0 log for scrapie, whereas for BSE the
reduction was on average just over 1-0 log. Process D was consid-
erably more effective than process C, especially for BSE infectivity:
three minutes at 134°C was thus more efficient than 15 minutes at
125°C. Process E (20 minutes at 133'C) reduced the infectivity of
scrapie by more than 1-7 log in series 1, and by more than 2-2 log
in series 2. With undiluted brain material (code P in series 2) the
infectivity of scrapie was reduced by more than 3-1 log (all calcu-
lated by the Karber method).
For BSE process E reduced the titre of infectivity by about 2-2
log (calculated by both mathematical methods) in series 1, and by
more than 2 log in series 2. With undiluted brain material (code P)
the inactivation was about 3 log by the Karber method.
Discussion
These experiments can be considered to be complementary to
the pilot-scale rendering experiments described by Taylor and oth-
ers (1995, 1997). They used a broad range of time-temperature
protocols and simulations of different rendering processes, where-
as the present experiments focused on the efficacy of hyperbaric
procedures for inactivating BSE and scrapie agents.
Although the study was initially planned to evaluate Dutch ren-
dering conditions (which are largely comparable with the German
and the Belgian processes), its results may have a wider bearing
since the implementation of the EU Directive on rendering in 1996
(Commission Decision 1996), stipulating that mammalian meat
and bone meal may only be fed to mammals if it has been pro-
TABLE 3: Reduction of titres of infectivity in the experiments of series 2
Titre after heat treatment Reduction factor*
Process Strain of (log ID50/g) (log 10)
Spiking agent Code (time/temp) mice Karber GLM (se) Karber GLM
Scrapie A 3 min/1050C C57BL 4.0 4.0 (0-2) - -
B 3 min/121°C C57BL 2.8 2.3 (0-3) 1.2 1.7
C 15 min/125°C C57BL 2.2 1.8 (0-2) 1.8 2.2
D 3 min/134°C C57BL NC 1.4 (0-5) NC 2.6
E 20 min/133°C C57BL <1 8 <1.3 (0-3) >2.2 >2.7
Pt 20 min/133°C Rill <0.8 <0.3 (0-2) >3.1t >3.7
BSE A 3 min/1050C Rill 3.8 3.8 (0-2) - -
B 3 min/121°C RIII 3.7 2.8 (0-1) 0.1 1-0
C 15 min/1250C Rill 2.8 2.7 (0.2) 1.0 1 1
D 3 min/1340C RIII -1.6 1.3 (0-3) 2.2 2.5
E 20 min/133°C Rill <1 8 <1.3 (0-3) >2.0 >2.5
Pt 20 min/133°C Rill <0-8 <0-3 (0-3) >3.0 >3.5
All titres were calculated by the method of Karber and using a generalised linear model (GLM) (se = standard error) and calculated back to 100 per cent brain
material
All titres indicated with 'smaller than' (<) had no detectable residual infectivity even in the highest concentration used in the bioassay (in this series applicable
to processes E and P [scrapie] only)
* The titre in process A (lowest heat exposure) was used as the reference titre. The reduction factor was calculated by the same mathematical method each
time
tThe titre in process A of series was used as the reference value, because this was the only one-available for scrapie in RIII mice
t Code P represents undiluted brain material
NC Not calculated owing to limited number of mice
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FIG 2: Reductions in the titres of infectivity of scrapie and BSE in the experiments of series I and 2. * Reduction exceeded measuring windo'A of
study
duced by a hyperbaric process for at least 20 minutes at 133°C at
3 bar.
The experiments covered only part of the total rendering pro-
cess, but they nevertheless provide an indication of what to expect
from the rendering process stipulated by EU directives. The labora-
tory scale of the experiments also requires to be taken into account
when they are comupared with coimmercial scale processes in which
additional variables such as the dilution of infective material, parti-
cle size, heat penetration time, stirred vessels, and so on need to be
considered. To address these issues, studies of the entire rendering
process need to be carried out. The pilot-scale experimiienits carried
out in the iTK by Taylor and others ( 1995, 1997) provide part of the
answer, but for hyperbaric processes comparable to the 3 bar for
20 minutes process. they only indicate that inactivation will be at
least 80f-old in the case of BSE. The present experiments also pro-
side essential inputs for modelling studies to calculate the risks
involved by the inclusion of meat and bone meal in teed for rumi-
nanlts, whether purposely as in the past, or accidentally as the result
of cross-contamination within the system.
One of the aims of the study was to deter-minie qualltitatively the
inactivation kinetics of the agcnts during, hyperbaric heat-treat-
ment processes, so that. for any desi-ed reductioni of iniectivity,
the required treatmiient could be calculated without the need for
animnal experimllents. Unfortunately, this proved impossible with
the data obtained. The main reason was that for a reliable calcula-
tion of the inactivation kinetics, a dose-response curve derived
from a range of experimental results within the measurine range
of the assay is needed. The results which ease either a zero reduc-
tion or were below the detection level of 10' 8 ID50/g (for which it
could not be established how far below the detection level they
were) could not be used for the calculation, but only as controls of
the outcome. The measuring range was only about 2 log (3 locg in
the undiluted series) and there were unfortunately too few results
within this ranee to make a reliable calculation. Whether the inac-
tivation of prions follows first order inactivation kinetics with
characteristic D- and z-values cannot therefore be answered on the
basis of the data obtained.
One of the basic limitations of this type of experimenit is not the
scale on which they are carried out, but the injection material
used. Thle 'natu-ral' hosts were selected as providers of the
source material, and the spike miaterial was mixed with render-
inc mater-ial, to reduce the uncer-tainties in interpreting the
results. It would have been possible to work with strainis of tiSE
agents that had already been passaged in the same exper-imiieni-
tal animlals as used in the bioassay. in which case the initial
titre would have beeni much higher and thus the measuringC
rang-e larger. The agents' therm-iior-esistanice could, however-,
have changed during this process of adaptation, and it was
therefore decided to woik directly with bovine BSE anld oviine
scrapie-infected materials.
Primary inoculaltions of scI-apie aind BSE in the miCe Usinl0
0-02 and 0-03 ml intracer-ebi-al inoculaltionis only. in ceiner-al
show titres approximiiately only ) log, higher th'an the spikin1g
material used in this study (Hadlow and others 1979, Fraser
anld others 1992). This difference cani be explained by differ-
ences in the route anid size of the inoculutnl i onlyI () ml
intracerebrally (and (01 ml intraper-itonieally had beell used
(doses which aire known to be as eflticienit as 0.02 ml intracere-
brally comiibined with 0(5 mil intraperitonea.llly) (Taylor anid oth-
ers 1994). the tities per- ml wotuld hasve been about 0(6 log
highei-. Compar-ed with the rendering studies of Taylor and oth-
ers ( 1995, 1997). the titres of the spike materiall were approxi-
miately 0.5 log lower in the case of- scr-apie wheni meaIsur-ed in
('57BL iice, whereaLs the level of infectivity of BSE mleaSLuIed in
the saime strain of' imiice (RutI) was about 10( log higher in the
authors' material. The titre of BSE-infeCtiVity was also of the
same order of magnitude as the results of other inactivation
studies have indicated (Taylor and others 1994).
Although it could be argued that the increase in the titre of
BSE after process A (Tables 2 and 3) indicates a technical prob-
lem, the authors consider that the difference in titres was within
acceptable errors of measurement. A secoind possible problem,
especially relevant to the scrapic material, is that thei-e may
have beei several strains in the spike materi-al, which Could
have had different levels of thermostability. This would have
intertered with the calcullation of the titres of infectivity.
When the inoculations of the heat-treated materials beg,an,
the C57BL Imice used for the scrapie materials started to give
478
4
Series 1 Scrapie
3
2
0,
0-
0
ax
cc
A
0
4
cm
0_-
'0
4-
at
cc
2
E P
o
|
_ |_
_
_ _
se _ [
A B C D
Process code
E P
 group.bmj.com on December 14, 2011 - Published by veterinaryrecord.bmj.comDownloaded from 
The Veterinary Record, May 2, 1998
problems immediately after the intracerebral injections. By
inoculating the various components of the inoculum separately,
it was concluded that a hypersensitivity associated with one of
the components of the antibiotic solution used to dilute the
inoculum was responsible. The same problem occurred later at
the NPU in Edinburgh (D. Taylor, personal communication).
Because of the problems encountered with the C57BL mice, it
was necessary to change to RIII mice for the heat-treated scrapie
materials in series 1. Unfortunately, no reference titre was
available for the original spike material in this line of mice. The
titre in the lowest heat treatment cycle (process A) in RIII was
therefore used as a reference. It was considered that this was
justified because the material was being prepared in one batch
in each series of experiments, which may be considered more
comparable than the undiluted spike material. In addition, it
was not expected that process A would have any detectable
inactivating effect. For reasons of homology, similar procedures
were used in calculating the results of the BSE materials in series
I and for both scrapie and BSE materials in series 2.
An additional advantage of using the titre in the lowest heat
treatment cycle (process A) as a reference titre was that,
because ruminant material was not specifically excluded, any
accidental contamination with TSE infectivity from the raw
material used for diluting the spike material would be account-
ed for. The chance that any clinically positive animals, in par-
ticular BSE-infected animals, might have been included in the
waste material used for the experiments, is considered to have
been remote.
The presently EU-endorsed process E (20 minutes at 133°C
at 3 bar), gave a reduction of infectivity for scrapie of rather
more than 2.0 log, taking the average of both series of experi-
ments. The results with undiluted scrapie brain material sug-
gest that the inactivation was more than 3 1 log. No residual
infectivity was found in these scrapie experiments.
For BSE in series 1 process E gave a reduction of infectivity
of about 2-2 log, and in series 2 it gave a reduction of more
than 2-0 log. With undiluted brain material (code P) the inacti-
vation was about 3 log. This is a refinement of the results of
the pilot scale experiments done in the UK by Taylor and others
(1995) which indicated for hyperbaric processes an inactiva-
tion of at least 80-fold for BSE. The reductions in titre of BSE
and scrapie infectivity by processes that were considered the
theoretical worst case scenarios for the two plants in the
Netherlands in the early 1990s were 0-5 and 15 logs smaller.
The BSE agent consistently appeared to be more resistant to
heat inactivation procedures than the scrapie agent, particularly
in processes involving lower temperatures for shorter times.
A possible explanation for the relatively low efficacy of pro-
cess E, at least in series 1, may be that within the mixed mate-
rial, prions were partitioned partially in the fat component, and
were thereby protected from the exposure to wet heat. Heat is
less effective in inactivating TSE agents in a lipid environment
than in conditions with saturated steam. Stirring might improve
the efficacy of inactivation for such a process. However, in
other rendering studies, tallow has not been shown to contain
any infectivity (Taylor and others 1995, 1997). Another possi-
ble explanation could be protective aggregation, in which some
of the agent survives owing to the influence of its molecular
micro-environment (Rohwer 1984).
Comparative titrations of the BSE agent in mice and cattle
have now indicated that cattle can be as much as 1000 times
more susceptible to intracerebral exposure to the BSE agent
than mice (R. Bradley, personal communication, G. A. H.
Wells and S. A. C. Hawkins, unpublished observations). This
implies that even after process E, the residual level of BSE
infectivity could be considerable, notwithstanding that the
above experiments involved intracerebral inoculations rather
thanoral exposure. The efficacy ofexposure by the oral route
is generally assumed to be about105 times less than exposure
by the intracerebral route (Kimberlin 1994). These factors
could, together with the results of inactivation studies, form the
basis of risk assessment studies or experimental transmission
studies with cattle as the target animals.
The results of these experiments indicate that with the EU
recommended process E (20 minutes at 133°C at 3 bar), BSE
infectivity was reduced by approximately 150 and 1000-fold,
when measured in the diluted and undiluted form, respectively.
These results would not guarantee an absolute absence of any
risk for ruminants which may be fed material which contained
high levels of BSE-infectivity when it entered the rendering
process. This residual risk has also been indicated by Taylor
(1997). The residual risk from material containing high levels
of BSE infectivity is expected to be blocked by the ban on ren-
dering specified risk material from ruminants (Commission
Decision 97/534/EC implementation postponed until April 1,
1998). Follow-up studies covering the entire rendering process,
together with risk assessment studies, could indicate whether
residual infectivity would constitute a tangible risk of propa-
gating an epidemic of BSE.
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Acute phase toxoplasma abortions in sheep
M. R. Owen, M. J. Clarkson, A. J. Trees
Veterinary Record (1998) 142, 480-482
Within 13 days of the experimental infection of 15 oestrus-
synchronised ewes with 2000 sporulated oocysts of
Toxoplasma gondii at 80 to 90 days of gestation 11 had abort-
ed. The infection induced pyrexia and specific antibody in all
the ewes. One ewe resorbed its fetus, 11 ewes aborted and
three delivered, at full term, live congenitally infected lambs
whose pre-colostral serum was antibody-positive. Tissues
from the aborted fetuses and placentae from the live lambs
were examined for toxoplasma infection by polymerase chain
reaction (PCR) amplification of the Bi gene and by mouse
inoculation. The live lambs were all shown to be infected by
both methods, but there was no evidence of infection in any of
the tissues from the acute phase abortions, suggesting that
these fatalities occurred before the placenta or the fetus had
been invaded by T gondii. Such toxoplasma-induced, acute-
phase abortions are likely to be impossible to diagnose from
fetal tissues. These results have implications not only for the
diagnosis of naturally occurring ovine abortions but also for
the understanding of the pathogenesis of toxoplasma-induced
abortion.
TOXOPLASMOSIS is a significant cause of abortion, neonatal
mortality and reproductive losses in sheep in Britain (Blewett and
Watson 1984, Blewett and Trees 1987), and many other countries
(Dubey and Towle 1986). Reproductive losses typically occur
only when a ewe contracts a primary infection during pregnancy.
Infection during early pregnancy may lead to fetal death and
resorption so that the ewe appears barren, whereas infection
between approximately 50 and 120 days gestation leads to abor-
tion late in gestation, or the birth of stillborn or weakly lambs
which may be accompanied by a mummified fetus (Beverley
1976, Buxton 1989). Placental cotyledons from these infected
lambs and aborted fetuses may show characteristic small white
necrotic foci while the intercotyledonary membranes are normal.
In such cases, the characteristic gross pathology and specific anti-
body to Toxoplasma gondii in fetal fluids, detectable three weeks
after infection of the ewe, are diagnostic of toxoplasmosis
(Buxton and Finlayson 1986). However, experimental infections
of pregnant ewes with T gondii oocysts indicate that a proportion
of ewes abort as early as seven to 12 days after infection (Dubey
and others 1987, Trees and others 1989), presumably owing to the
pyrexia induced by the infection (McColgan and others 1988).
The placentae from such abortions do not show the characteristic
lesions of focal necrosis typical of toxoplasmosis (McColgan and
others 1988) and fetal fluids from such abortions are negative for
toxoplasma antibodies (Dubey and others 1987, Trees and others
1989).
The extent to which acute phase abortions occur in natural
cases of ovine toxoplasmosis is unknown and may well be under-
estimated (Trees and others 1989), owing to diagnostic difficul-
ties. Using a nested polymerase chain reaction (PCR) technique for
the detection of T gondii, tissues from acute phase abortions
resulting from experimental infections have been examined for
evidence of T gondii infection. This PCR technique has been
shown to be equal in sensitivity to mouse inoculation (Owen and
others 1998).
Materials and methods
Experimental infections
Eighteen Welsh half-bred ewes, without detectable T gondii-
specific antibody (see below), were oestrus-synchronised, mated
and confirmed pregnant at 60 to 70 days gestation by ultrasound
examination. Between 80 to 90 days of gestation, 15 ewes were
dosed with 2000 sporulated toxoplasma oocysts of the Ml isolate
(Buxton and others 1979). Three ewes were kept with the infected
groups as sentinel control animals to allow any adventitious toxo-
plasma infection to be detected. The animals' rectal temperatures
were measured from two days before infection to 14 days after
infection. The infections were confirmed by postinfection pyrexi-
as and an eight-fold increase in T gondii antibody titre after 21
days (Blewett and others 1983). Tissues from the aborted fetuses
and fetal membranes from the live lambs were collected and tested
for toxoplasma infection by mouse inoculation and PCR. Samples
of thoracic fluid from the aborted fetuses, pre-colostral serum from
the live lambs and serum from the ewes taken before and seven, 14
and 21 days after infection were tested for toxoplasma-specific
antibody.
Serology
M. R. Owen, PhD, BSc, MRCVS, A. J. Trees, PhD, BVM&S, MRCVS,
Department of Veterinary Parasitology, Liverpool School of Tropical
Medicine/Faculty of Veterinary Science, University of Liverpool, Pembroke
Place, Liverpool L3 5QA
M. J. Clarkson, PhD, DVSc, BSc, DSHP, MRCVS, Department of Veterinary
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University of Liverpool, Leahurst, Chester High Road, Neston, South Wirral
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Toxoplasma antibody in the sheep and live lambs was assayed
by the latex agglutination test (Eiken Chemical Company) (Trees
and others 1989), using a dilution of 1/64, and in mice and aborted
lambs by the modified agglutination test (Biomerieux) which is
more sensitive than the latex agglutination test for aborted lambs
(Dubey and others 1987). For the modified agglutination test sera
were assayed at dilutions of 1/40 and 1/4000, the latter to detect
false negative results which can occur when testing serum with a
high antibody titre at low dilutions.
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